Are Pharmacological Randomised Controlled Clinical Trials Relevant to Real-life Asthma Populations? A Protocol for an UNLOCK Study from the IPCRG

Overview

Journal NPJ Prim Care Respir Med

Specialties Public Health
Pulmonary Medicine

Date 2016 Apr 15

PMID 27074713

Citations 4

Authors

Karin Lisspers

Pedro Teixeira

Coert Blom

Janwillem Kocks

Bjorn Stallberg

David Price

Niels Chavannes

Affiliations

Soon will be listed here.

Citing Articles

Perspectives on decisions for treatment and care in severe asthma.

Winders T, Maspero J, Callan L, Al-Ahmad M World Allergy Organ J. 2021; 14(1):100500.

PMID: 33537114 PMC: 7817505. DOI: 10.1016/j.waojou.2020.100500.

Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Roche N, Campbell J, Krishnan J, Brusselle G, Chisholm A, Bjermer L Clin Transl Allergy. 2019; 9:20.

PMID: 30962875 PMC: 6436229. DOI: 10.1186/s13601-019-0255-x.

Effectiveness trials: critical data to help understand how respiratory medicines really work?.

Heddini A, Sundh J, Ekstrom M, Janson C Eur Clin Respir J. 2019; 6(1):1565804.

PMID: 30728925 PMC: 6352944. DOI: 10.1080/20018525.2019.1565804.

Effectiveness of an annular closure device in a "real-world" population: stratification of registry data using screening criteria from a randomized controlled trial.

Kursumovic A, Rath S Med Devices (Auckl). 2018; 11:193-200.

PMID: 29922099 PMC: 5995288. DOI: 10.2147/MDER.S167381.

References

Reddel H, Sawyer S, Everett P, Flood P, Peters M . Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015; 202(9):492-7. DOI: 10.5694/mja14.01564. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2011; 3(3):e123-30. PMC: 3090117. View

Fischer J, Wimmer A, Mahlich J . [Medication adherence in asthma therapy--a structured review]. Pneumologie. 2013; 67(7):406-14. DOI: 10.1055/s-0033-1344242. View

Harbour R, Miller J . A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323(7308):334-6. PMC: 1120936. DOI: 10.1136/bmj.323.7308.334. View

Kruis A, Stallberg B, Jones R, Tsiligianni I, Lisspers K, van der Molen T . Primary care COPD patients compared with large pharmaceutically-sponsored COPD studies: an UNLOCK validation study. PLoS One. 2014; 9(3):e90145. PMC: 3943905. DOI: 10.1371/journal.pone.0090145. View

Mims J . Asthma: definitions and pathophysiology. Int Forum Allergy Rhinol. 2015; 5 Suppl 1:S2-6. DOI: 10.1002/alr.21609. View

Roche N, Reddel H, Martin R, Brusselle G, Papi A, Thomas M . Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014; 11 Suppl 2:S99-104. DOI: 10.1513/AnnalsATS.201309-300RM. View

van Boven J, Trappenburg J, van der Molen T, Chavannes N . Towards tailored and targeted adherence assessment to optimise asthma management. NPJ Prim Care Respir Med. 2015; 25:15046. PMC: 4588030. DOI: 10.1038/npjpcrm.2015.46. View

Williams B . Perils of evidence-based medicine. Perspect Biol Med. 2010; 53(1):106-20. DOI: 10.1353/pbm.0.0132. View

10.

Wong G, Miravitlles M, Chisholm A, Krishnan J, Krishnan J . Respiratory guidelines--which real world?. Ann Am Thorac Soc. 2014; 11 Suppl 2:S85-91. DOI: 10.1513/AnnalsATS.201309-298RM. View

11.

Sadowski C, Cor K, Cave A, Banh H . Administration Technique and Acceptance of Inhaler Devices in Patients With Asthma or COPD. Ann Pharmacother. 2015; 49(6):639-48. DOI: 10.1177/1060028015579097. View

12.

Herland K, Akselsen J, Skjonsberg O, Bjermer L . How representative are clinical study patients with asthma or COPD for a larger "real life" population of patients with obstructive lung disease?. Respir Med. 2005; 99(1):11-9. DOI: 10.1016/j.rmed.2004.03.026. View

13.

Reddel H, Levy M . The GINA asthma strategy report: what's new for primary care?. NPJ Prim Care Respir Med. 2015; 25:15050. PMC: 4519996. DOI: 10.1038/npjpcrm.2015.50. View

14.

Chavannes N, Stallberg B, Lisspers K, Roman M, Moran A, Langhammer A . UNLOCK: Uncovering and Noting Long-term Outcomes in COPD to enhance knowledge. Prim Care Respir J. 2010; 19(4):408. PMC: 6602276. DOI: 10.4104/pcrj.2010.00084. View

15.

Lalloo U, Walters R, Adachi M, de Guia T, Emelyanov A, Fritscher C . Asthma programmes in diverse regions of the world: challenges, successes and lessons learnt. Int J Tuberc Lung Dis. 2011; 15(12):1574-87. DOI: 10.5588/ijtld.11.0289. View

16.

Travers J, Marsh S, Williams M, Weatherall M, Caldwell B, Shirtcliffe P . External validity of randomised controlled trials in asthma: to whom do the results of the trials apply?. Thorax. 2006; 62(3):219-23. PMC: 2117157. DOI: 10.1136/thx.2006.066837. View

17.

Sheehan W, Phipatanakul W . Difficult-to-control asthma: epidemiology and its link with environmental factors. Curr Opin Allergy Clin Immunol. 2015; 15(5):397-401. PMC: 4551573. DOI: 10.1097/ACI.0000000000000195. View

18.

Price D, Brusselle G, Roche N, Freeman D, Chisholm A . Real-world research and its importance in respiratory medicine. Breathe (Sheff). 2015; 11(1):26-38. PMC: 4487388. DOI: 10.1183/20734735.015414. View

19.

Price D, Hillyer E, van der Molen T . Efficacy versus effectiveness trials: informing guidelines for asthma management. Curr Opin Allergy Clin Immunol. 2012; 13(1):50-7. DOI: 10.1097/ACI.0b013e32835ad059. View

20.

Demoly P, Paggiaro P, Plaza V, Bolge S, Kannan H, Sohier B . Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev. 2010; 18(112):105-12. DOI: 10.1183/09059180.00001209. View